Congenital Hyperbilirubinemias Flashcards
Inherited hyperbilirubinemia disorders
Various inherited disorders
Hyperbilirubinemia in setting of normal liver function tests
Categories of inherited hyperbilirubinemia
- Unconjugated hyperbilirubinemia (Gilbert & Crigler-Najjar Type I/Type II)
- Conjugated hyperbilirubinemia (Dubin-johnson syndrome, Rotor syndrome)
Gilbert syndrome (unconjugated)
inherited unconjugated hyperbilirubinemia
2/2 mutations of bilirubin uridine diphosphate glucuronosyltransferase
Benign AR condition
Absent detectable functional or structural liver disease
Gilbert syndrome (unconjugated)
Epidemiology
Puberty; males»_space;
Related to increased Hb turnover & inhibition of bilirubin glucuronidation by endogenous steroid hormones
Gilbert syndrome (unconjugated)
Molecular
Extra TA in TATA box of UGT1A1 promoter (UGT1A1*28)
Gene transcription decreases to 20% of normal levels
Decreased conjugation of bilirubin w/ glucuronic acid & some drugs
Gilbert syndrome (unconjugated)
Associated
Decreased RBC life span,
HA, impaired hepatic bilirubin uptake
Fasting, illness, dehydration, cholelithiasis,
Hereditary spherocytosis
Gilbert syndrome (unconjugated)
Presentation
Low hepatic UDP-GT activity –> isolated unconjugated hyperbilirubinemia
Gilbert syndrome (unconjugated)
Risk fx –>
Toxicity from drugs metabolized by UGT
Decreased conjugation of some drugs (irinotecan, atazanavir, TAS-103, indinavir, tolbutamide, rifamycin)
Might be predisposed to acetaminophen toxicity
Gilbert syndrome (unconjugated)
Misdiagnosis
Chronic hepatitis
Gilbert syndrome (unconjugated)
Lab tests
Mild unconjugated hyperbilirubinemia –> increased proportion of bilirubin monoglucuronide
Normal: alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, gamma-glutamyl trasnpeptidase
Rifampin admin & caloric restriction –> causes disproportionate hyperbilirubinemia relative to normal
Crigler-Najjar Syndrome (type I) unconjugated hyperbilirubinemia
Complete absence of UDP-DT
Bilirubin glucuronides virtually absent from bile
No detectable constitutive expression of UGT1A1 in hepatic tissue
Serum unconjugated bilirubin >25 mg/dL
Crigler-Najjar Syndrome (type I) unconjugated hyperbilirubinemia
Presentation
AR
Die from encephalopathy (kernicterus) w/in first year of life
Crigler-Najjar Syndrome (type I) unconjugated hyperbilirubinemia
Treatment
Liver transplant –> only effective therapy
Phenobarbital w/o effect –> cytochrome p450 inducer –> upregulates expression of UDPGT –> decreases levels of unconjugated bilirubin
Crigler-Najjar Syndrome (type II) unconjugated hyperbilirubinemia
Partial deficiency of UDP-GT
Can be induced by infection, anesthesia, drug use
Serum bilirubin 5-20 mg/dL
AD
Crigler-Najjar Syndrome (type II) unconjugated hyperbilirubinemia
Treatment & Prognosis
Tx: Phenobarbital
Prog: Normal life expectancy
Dubin-Johnson Syndrome (conjugated)
Molecular
Mutations in CMOAT/MRP2/ABCC2 –> codes for ATP-dependent organic anion transport localized to canalicular membrane
AR
Dubin-Johnson Syndrome (conjugated)
Pathogenesis
Conjugated hyperbilirubinemia
Result in impaired biliary canalicular transport of organic anions, including conjugated bilirubin
Impaired glutathione excretion –> reduces bile salt-independent bile flow
Dubin-Johnson Syndrome (conjugated)
Micro
Coarse granular pigment in centrilobular hepatocytes
Deposition of brown-black melanin-like pigment in hepatocytes –> leads to blackening of liver
Iron stain NEGATIVE – not hemosiderin